DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/14892
Title: Cross-sectional study of zero-medicine markup policy, prescribing trends and drug indicators using WHO/INRUD methodology in Chinese Jingzhou area
Authors: Jun, Zou
Jingsong, Mei
Guohua, Jia
Yuanrong, Yang
Keywords: Cross-sectional study
markup policy
pharmacoepidemiology
rational use of drugs
economic data
drug indicator
prescribing trend
antibiotic percent
injection percent
Issue Date: 20-Jul-2022
Publisher: Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.
Citation: Jun, Z., Jingsong, M., Guohua, J., & Yuanrong, Y. (2022). Cross-sectional study of zero-medicine markup policy, prescribing trends and drug indicators using WHO/INRUD methodology in Chinese Jingzhou area. Pakistan Journal of Pharmaceutical Sciences, 35(4).
Abstract: In order to get the baseline data of Chinese Zero-Medicine Markup Policy, before any administrative intervention we investigated the drug indicators, the prescribing trends and economic data. In accordance with the WHO/INRUD criteria and cross-sectional studies, the retrospective methods along with equal sample interval of systematic sampling were used. We sampled from daily prescriptions and calculated the means over a twelve day period. We sampled from 38,246 adult prescriptions, the sampling percent was 3.06%, and the drugs prescribed by generic name were 100.00%. During 2012-2014, the percentage of antibiotic cost in the total daily drug cost decreased from17.44% to 8.01%, the percentage of prescriptions with antibiotic prescribed decreased from 12.64% to 9.64%, the percentage of encounters with an injection prescribed decreased from 15.21% to 12.77%. The average drug cost per antibiotic prescription ranged from ¥169.33 to 186.66. By comparing the related data, Zero-Medicine Markup Policy had greatly affected prescribing indicators, some indicators had a decreasing trend and became more rational, Zero-Markup Medicine Policy decreased both the patient-level and hospital-level drug expenses, and the reformation of the ZeroMedicine Markup Policy was steadily advanced.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/14892
ISSN: 1011-601X
Appears in Collections:Issue No.4

Files in This Item:
File Description SizeFormat 
3-10194.htm131 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.